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INTRODUCTION
Failure rates after primary ACL reconstruction range from 1.8 to 10.4%. 
Increased rates of ACL reconstruction has amplified the need for revision 
ACL reconstruction (rACLR) 
 rACLR in younger patients more likely to have higher incidence of 
concomitant meniscal and cartilage procedures 
 rACLR worse clinical outcomes compared to primary ACLR
Multicenter ACL Revision Study (MARS) group prospective longitudinal 
cohort of patients to evaluate outcomes of rACLR. 
Currently, there is a lack of information concerning rates and risk factors for 
further reoperation after rACLR
Hypothesis: Reoperations after rACLR result in decreased 
outcome scores and are associated with younger age and use 
of allograft. 
METHODS
Prospective case-control study (2006 – 2011)
• MARS Study: academic and private practice multicenter consortium 
(83 surgeons at 52 sites) funded by the National Institutes of Health 
and sponsored by AOSSM)
• 1205 patients enrolled
• Inclusion: 
• Patients who underwent rACLR
• Completion of patient-reported outcome questionnaires
• Exclusions:
• Inability or unwillingness to complete a 2-year follow-up survey,
• Graft failure secondary to prior intra-articular infection, 
arthrofibrosis, or complex regional pain syndrome.
DISCUSSION
This is the first study to note worsening patient-reported outcomes with 
reoperations after rACLR.
•Reoperations associated with younger-aged patients: 
• < 20 years old = 2.1 times higher risk of reoperation compared to 
patients in their 20’s
• younger patients who rupture their ACL may be likely to return to more 
aggressive cutting and pivoting sports, be less compliant with 
postoperative instructions, and/or have a genetic predisposition to 
collagen disruption impacting on their risk for ACL re-tear as well as 
meniscal and cartilage damage
•Allograft had 1.8-times greater risk for reoperation compared to autograft.
•Grade 4 chondral damage noted at the time of initial surgery was protective 
against reoperations within 2 years.
• May be due to the natural decrease in activity with increasing chondral 
damage as patients develop more arthritic joints and discomfort.  
• Furthermore, there may also be added impact of physician counseling 
that additional minimally invasive surgery would not be recommended 
given the severity of cartilage loss. 
CONCLUSIONS
There is a significant reoperation rate following rACLR at two years (10%). The 
most prevalent reoperations involved meniscal procedures.  Independent risk 
factors for subsequent surgery on the ipsilateral knee include age less than 20 
years, staged revision surgery and use of allograft tissue during rACLR.
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STATISTICS
• Pearson chi-squared test for analysis of categorical data
• Independent-samples t-test for continuous data
• Multivariable binary logistic regression analysis to determine factors 
associated with reoperations. 
• Repeated measures ANOVA used to assess for changes in patient-
reported outcome scores comparing rACLR patients who had subsequent 
surgery and those who did not. 
• Statistical significance was set for all analyses to P < .05. 
Table 1. Characteristics of Study Population
NO Reoperations Reoperations Total
Total Patients 1083 122 1205
Sex
Female 446 (41.2%) 62 (50.8%) 508 (42.2%)
Male 637 (58.8%) 60 (49.2%) 697 (57.8%)
Age Group
<20 249 (23%) 43 (35.2%) 292 (24.2%)
20-29 418 (38.6%) 33 (27%) 451 (37.4%)
30-39 254 (23.5%) 33 (27%) 287 (23.8%)
40-49 129 (11.9%) 9 (7.4%) 138 (11.5%)
>50 33 (3%) 4 (3.3%) 37 (3.1%)
BMI
Normal (18.5-24) 494 (45.6%) 62 (50.8%) 556 (46.1%)
Overweight (25-29) 385 (35.5%) 47 (38.5%) 432 (35.9%)
Obese (30-34) 151 (13.9%) 9 (7.3%) 160 (13.3%)
Morbidly Obese (>35) 53 (4.9%) 4 (3.3%) 57 (4.7%)
Smoking
Never   824 (76.1%) 99 (81.1%) 923 (76.6%)
Quit 140 (12.9%) 14 (11.5%) 154 (12.8%)
Current 101 (9.3%) 8 (6.6%) 109 (9%)
Unknown 18 (1.7%) 1 (0.8%) 19 (1.6%)
Baseline Marx
0-4 301 (27.8%) 35 (28.7%) 336 (27.9%)
5-8 131 (12.1%) 11 (9%) 142 (11.8%)
9-12 246 (22.7%) 24 (19.7%) 270 (22.4%)
13-16 398 (36.7%) 51 (41.8%) 449 (37.3%)
Table 2. Multivariate Regression Predicting Re-Operation after 
Revision ACL
OR (95% CI) P
GENDER: Male vs. Female 1.30 (0.85, 1.99) 0.229
AGE: ref.=<20
20-29 0.47 (0.27, 0.81) 0.007
30-39 0.87 (0.478, 1.57) 0.640
40-49 0.58 (0.25, 1.36) 0.212
50-59 0.99 (0.29, 3.40) 0.989
BMI: ref.= Normal (17-25)
Overweight (25-29) 1.33 (0.85, 2.09) 0.211
Obese (30-34) 0.53 (0.25, 1.15) 0.107
Morbidly Obese (35-40) 0.68 (0.23, 2.04) 0.490
SMOKING HISTORY:  ref.= Never
Current 0.72 (0.33, 1.59) 0.417
Quit 0.90 (0.48, 1.70) 0.752
MARX SCORE: ref.= 0-4
5-8 0.67 (0.32, 1.40) 0.285
9-12 0.86 (0.48, 1.54) 0.611
13-16 0.88 (0.52, 1.51) 0.649
STAGING: ref.=single stage revision
Two-stage revision (bone grafting 
before revision)
2.08 (1.12, 3.88) 0.021
ACL GRAFT: ref.= Autograft
Allograft 1.83 (1.21, 2.78) 0.004
Hybrid auto-allograft 2.53 (0.96, 6.65) 0.060
HIGHEST CARTILAGE GRADE: ref.= Grade 1
Grade 2 1.16 (0.72, 1.89) 0.539
Grade 3 1.59 (0.84, 3.02) 0.155
Grade 4 0.45 (0.24, 0.87) 0.018
FEMORAL TUNNEL TECHNIQUE: ref.= Transtibial drilling
Anteromedial portal drilling 0.97 (0.63, 1.51) 0.905
Two-incision- outside-in drilling 1.38 (0.80, 2.38) 0.250
MENISCUS: ref.= No tear
Partial tear 2.47 (0.12, 50.9) 0.559
Complete tear 2.13 (0.11, 42.8) 0.622
MENISCUS TREATMENT: ref.= normal meniscus
No Treatment for partial tear 0.51 (0.02, 11.6) 0.670
Meniscectomy 0.49 (0.02, 9.94) 0.642
Repair 0.81 (0.04, 16.6) 0.890
Other (Transplant) 0.72 (0.03, 15.8) 0.836
Table 3. Patient-Reported Median (25%, 75% quartile) Outcome 
Scores over Time
Total NO Reoperations Reoperations P-Value 
Baseline 2-year Baseline 2 Year Baseline 2 Year
IKDC 51(37, 63) 77(60, 86) 51(37, 63) 78(63, 87) 50(38, 64) 66(48, 81) 0.005
KOOS
Symp 67(53, 82) 78(64, 89) 67(53, 82) 82(67, 92) 64(50, 78) 71(57, 82) 0.001
Pain 75(58, 86) 88(75, 94) 75(58, 86) 91(77, 97) 72(58, 86) 83(69, 91) 0.034
ADL 86(69, 95) 97(88, 100) 86(69, 95) 97(89, 100) 83(64, 95) 94(83, 98) 0.157
Sports 45(25, 65) 75(55, 90) 45(25, 65) 75(55, 90) 45(25, 65) 65(37, 80) 0.063
QOL 31(18, 43) 56(37, 75) 31(18, 43) 62(43, 75) 37(18, 50) 50(31, 68) 0.248
WOMAC
Stiff 75(50, 87) 75(62, 100) 75(50, 87) 75(62, 100) 62(50, 87) 75(62, 87) 0.020
Pain 85(70, 95) 95(80, 100) 85(70, 95) 95(80, 100) 80(70, 95) 90(75, 95) 0.089
ADL 86(69, 95) 97(88, 100) 86(69, 95) 97(89, 100) 83(64, 95) 94(83, 98) 0.157
Marx 11(4, 16) 7(2, 12) 11(4, 16) 7(2, 12) 11(4, 16) 6(3, 12) 0.529
